ArticleViewAbstractPharmacognosy Journal,2024,16,3,570-575.DOI:10.5530/pj.2024.16.89Published:June 2024Type:Original ArticleEfficacy and Safety of Traditional Transdermal Patch (Ya-Pok- Dud-Pid) in Primary Knee Osteoarthritis Patients: A Randomized Controlled TrialChutharat Saereewat, Kusuma Sriyakul, Parunkul Tungsukruthai, Sunyarn Niempoog, Sucharat Tungsukruthai, and Chuntida Kamalashiran Chutharat Saereewat1, Kusuma Sriyakul1, Parunkul Tungsukruthai1, Sunyarn Niempoog2, Sucharat Tungsukruthai3, Chuntida Kamalashiran1* 1Department of Integrative Medicine, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND. 2Department of Orthopedic, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND. 3Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, THAILAND. Abstract:Background: Patients with Knee Osteoarthritis (KOA) have a progressive decline in their social and physical abilities, which affects their quality of life. The Thai Traditional Transdermal Patch (Ya-Pok-Dud- Pid; YP) has been widely used for the treatment of KOA. Objective: To determine the clinical efficacy and safety of YP in comparison with diclofenac gel (DG) for the treatment of KOA. Methods: 74 primary KOA Patients were enrolled and randomly assigned to YP groups or DG groups. The outcomes were assessed the Visual Analog Scale (VAS), Time Up and Go (TUG), Active Knee Flexion (AKF) and Passive Knee Flexion, chair sit and reach, and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Results: YP and DG significantly improved VAS, TUG, AKF, PKF, chair sit and reach, and WOMAC (p < 0.05). Remarkably, YP experienced the same immediate pain relief after day 1 treatment as DG. The VAS scores of the YP group exhibited a significant reduction from 60±11.06 to 38.92±17.76, while DG decreased VAS score from 61.24±17.84 to 39.19±20.05 (p <0.001). However, there was no significant difference between the two treatment groups. For adverse event, skin reaction (rash, itchy, and dry skin) was noted in the YP group because of the participant receiving YP for an extended period. Altogether, YP has a similar effect to diclofenac gel on pain severity and physical function in patients with knee osteoarthritis. Conclusion: YP is recommended as a natural therapeutic agent with efficacy and safety treatment for knee osteoarthritis. Keywords:Diclofenac, Osteoarthritis of knee, Traditional, Transdermal PatchView:PDF (416.31 KB) PDF Images Flow chart of participants. ‹ The Effect of Cryopreservation on the Sperm Ultrastructure of Mus Musculus Albinus Strain DDY: Comparison of Nakagata vs Modified vs Kitazato Cryoprotectants up Evaluation of Potential Toxicity Associated with Antidiabetic Herbs in Saudi Arabia ›